Case Western Reserve University, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106, United States
NCT Number: NCT03290430
The purpose of this research is to study a smoking cessation program for adult smokers in Northeast Ohio. The study will also look at how different people respond to the program.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Early Phase 1
Cleveland, Ohio, 44106, United States
Objective 1: To examine the feasibility of conducting an evidence-based, cognitive behavioral therapy (CBT) for tobacco cessation delivered in multiple formats. Participants will have the opportunity to receive a CBT-based tobacco intervention delivered several possible formats (face-to-face, telephone, video-counseling) based on availability and participant preferences. Study participants will be exposed to cognitive-behavioral cessation and relapse prevention strategies, and discuss barriers to cessation, previous quit attempts, risky situations, and benefits observed after quitting. Participants may also complete exercises designed to assist cessation attempts (e.g., mental and behavioral coping skills, cognitive reframing exercise, health benefits of cessation; and no-smoking behavioral contracts). As supplemental treatment, participants may have the option to receive up to 8 weeks of nicotine replacement therapy and text-messaging support.
Objective 2: To examine the rates of smoking abstinence across intervention formats. Investigators will attempt to follow-up with participants for a 6-months after program completion. Investigators will assess point prevalence abstinence for each intervention delivery method.
Objective 3: To assess individual difference variables that influence outcomes. Investigators will examine individual-difference predictors of outcomes, such as readiness to quit, social support, distress, and environmental factors.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8 sessions over 4 weeks. Lasting 1-2 hours each
8 in person sessions over 4 weeks. Lasting 30-45 minutes each
8 phone sessions over 4 weeks. Lasting 30-45 minutes each
8 video call sessions over 4 weeks. Lasting 30-45 minutes each
Texts with smoking cessation support throughout the program
Participants will receive up to 8 weeks of over-the-counter nicotine replacement therapy
Other names: Nicotine Patch, Nicotine Gum, NRT
Time frame: Up to 24 hours after session 1
Number of participants who did not smoke for 24 hours. Coded as binary (1 = cessation, 0 = smoking)
Time frame: Up to 7 days after session 1
Number of participants who did not smoke for 7 days (1 = cessation, 0 = smoking)
Time frame: Up to 28 days after session 1
Number of participants who did not smoke for 28 days (1 = cessation, 0 = smoking)
Time frame: Up to 4 weeks after session 1
Scaled survey will be used to assess the quality and the content of the intervention [i.e., the extent to which the content was informative, encouraging, attention capturing, credible, applicable to their lives, and comprehensible.]
Time frame: Up to 4 weeks after session 1
Average count of sessions each participant completed (1-8)
Time frame: Up to 4 weeks after session 1
Time frame: Up to 4 weeks after session 1
Average count of doses of NRT taken by participants
Case Comprehensive Cancer Center
Other
End Nicotine Dependence (END) Clinic
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03950427
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT03083353
Behavior, Chemically-Induced Disorders
Austin, Texas, United States
View Trial DetailsNCT05952401
Behavior, Chemically-Induced Disorders
St Louis, Missouri, United States
View Trial DetailsNCT05729243
Alcohol Use Disorder, Alcohol-Related Disorders
Toronto, Ontario, Canada
View Trial Details